Chronic venous disease (CVD) is a vascular disorder in which blood return is severely compromised and CVD is usually characterized by venous hypertension. Along with obesity and diabetes mellitus, CVD is one of the most common civilization diseases. In general, the estimated prevalence of CVD ranges from 60-80 %. Early diagnosis and adequate treatment are important for preventing progression to more severe stages of the disease like venous leg ulcers. Clinical manifestations of CVD in initial stages of the disease are often asymptomatic. However, as CVD progresses, symptoms begin to develop. Treatment of CVD could be divided into conservative and surgical. Conservative therapy consists of compression, pharmacological treatment and lifestyle change. In cases where conservative therapy is ineffective, surgical or endovascular treatment may be required. The intersections between diabetes mellitus (DM) and CVD are not to be underestimated. CVD and DM have often the same risk factors. Symptoms of CVD can be modified by late complications of DM, but the incidence of different CVD degrees seems to be the same as in diabetics as in non-diabetics population. We are particularly concerned in diabetics about worse compliance with treatment due to their often-poorer adherence to treatment of DM and lifestyle changes. Moreover, there exist a higher risk of CVD and peripheral arterial disease in diabetics patients. Patients with CVD should always be inspected for the presence of DM, considering its presence can have a bearing on CVD symptoms, diagnostic procedures, and therapeutic strategies.

Diabetes Centre Institute for Clinical and Experimental Medicine Praha 4 Czech Republic

See more in PubMed

Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F, Pekarek L, et al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J Clin Med. 2021;10:3239. doi: 10.3390/jcm10153239. PubMed DOI PMC

Karetová D, Chochola M, et al. Vaskulární medicína. In Czech; Maxdorf, Praha: 2018. pp. 340–351.

Piazza G. Varicose veins. Circulation. 2014;130:582–587. doi: 10.1161/CIRCULATIONAHA.113.008331. PubMed DOI

Robertson L, Lee AJ, Gallagher K, Carmichael SJ, Evans CJ, McKinstry BH, Fraser SCA, et al. Risk factors for chronic ulceration in patients with varicose veins: a case control study. J Vasc Surg. 2009;49:1490–1498. doi: 10.1016/j.jvs.2009.02.237. PubMed DOI

Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP, Nikishkov AS, Tatarintsev AM, Kirienko AI. Prevalence and risk factors for chronic venous disease in the general Russian population. Eur J Vasc Endovasc Surg. 2017;54:752–758. doi: 10.1016/j.ejvs.2017.08.033. PubMed DOI

Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175–184. doi: 10.1016/j.annepidem.2004.05.015. PubMed DOI

Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31:105–115. PubMed

Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F, Pekarek L, et al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J Clin Med. 2021;10:3239. doi: 10.3390/jcm10153239. PubMed DOI PMC

Rabe E, Berboth G, Pannier F. Epidemiology of chronic venous diseases. Wien Med Wochenschr. 2016;166:260–263. doi: 10.1007/s10354-016-0465-y. PubMed DOI

Guest JF, Fuller GW, Vowden P. Venous leg ulcer management in clinical practice in the UK: costs and outcomes. Int Wound J. 2018;15:29–37. doi: 10.1111/iwj.12814. PubMed DOI PMC

O'Donnell TF, Jr, Passman MA, Marston WA, Ennis WJ, Dalsing M, Kistner RL, Lurie F, et al. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery® and the American Venous Forum. J Vasc Surg. 2014;60(2 Suppl):3S–59S. doi: 10.1016/j.jvs.2014.04.049. PubMed DOI

Kolluri R, Lugli M, Villalba L, Varcoe R, Maleti O, Gallardo F, Black S, Forgues F, Lichtenberg M, Hinahara J, Ramakrishnan S, Beckman JA. An estimate of the economic burden of venous leg ulcers associated with deep venous disease. Vasc Med. 2022;27:63–72. https://doi.org/10.1177/1358863X211028298Erratum in: Vasc Med 2022;27:NP1 https://doi.org/10.1177/1358863X211048020. PubMed DOI PMC

Ligi D, Croce L, Mannello F. Chronic venous disorders: the dangerous, the good, and the diverse. Int J Mol Sci. 2018;19:2544. doi: 10.3390/ijms19092544. PubMed DOI PMC

Raffetto JD. Pathophysiology of wound healing and alterations in venous leg ulcers - review. Phlebology. 2016;31:56–62. doi: 10.1177/0268355516632998. PubMed DOI

Štork J, et al. Dermatovenerologie 1. vydání. In Czech; Galén, Praha: 2008. pp. 330–332.

Matic M, Matic A, Djuran V, Gajinov Z, Prcic S, Golusin Z. Frequency of peripheral arterial disease in patients with chronic venous insufficiency. Iran Red Crescent Med J. 2016;18:e20781. doi: 10.5812/ircmj.20781. PubMed DOI PMC

Carpentier PH, Maricq HR, Biro C, Ponçot-Makinen CO, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg. 2004;40:650–659. doi: 10.1016/j.jvs.2004.07.025. PubMed DOI

Anwar MA, Georgiadis KA, Shalhoub J, Lim CS, Gohel MS, Davies AH. A review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet. 2012;5:460–466. doi: 10.1161/CIRCGENETICS.112.963439. PubMed DOI

Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH. Importance of the familial factor in varicose disease: clinical study of 134 families. J Dermatol Surg Oncol. 1994;20:318–326. doi: 10.1111/j.1524-4725.1994.tb01631.x. PubMed DOI

Carman TL, Al-Omari A. Evaluation and management of chronic venous disease using the foundation of CEAP. Curr Cardiol Rep. 2019;21:1–8. doi: 10.1007/s11886-019-1201-1. PubMed DOI

Fejfarová V, Roztočil K, Svědínková A, Čermáková H, Dubský M, Bém R, Jirkovská A, Wosková V, Němcová A, Skibová J. The relationship between chronic venous insufficiency and diabetes mellitus. Int Angiol. 2017;36:90–91. doi: 10.23736/S0392-9590.16.03736-6. PubMed DOI

Castro-Ferreira R, Cardoso R, Leite-Moreira A, Mansilha A. The role of endothelial dysfunction and inflammation in chronic venous disease. Ann Vasc Surg. 2018;46:380–393. doi: 10.1016/j.avsg.2017.06.131. PubMed DOI

Imbernón-Moya A, Ortiz-de Frutos FJ, Sanjuan-Alvarez M, Portero-Sanchez I. Chronic venous disease of legs. Med Clin. 2017;148:371–376. doi: 10.1016/j.medcli.2017.01.001. PubMed DOI

Trayes KP, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and management. Am Fam Physician. 2013;88:102–110. doi: 10.1097/ACM.0b013e318277d5b2. PubMed DOI

Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333–346. doi: 10.1161/CIRCULATIONAHA.113.006898. PubMed DOI

Necas M. Duplex ultrasound in the assessment of lower extremity venous insufficiency. Australas J Ultrasound Med. 2010;13:37–45. doi: 10.1002/j.2205-0140.2010.tb00178.x. PubMed DOI PMC

Urbanek T, Juśko M, Kuczmik WB. Compression therapy for leg oedema in patients with heart failure. ESC Heart Fail. 2020;7:2012–2020. doi: 10.1002/ehf2.12848. PubMed DOI PMC

Dissemond J, Storck M, Kröger K, Stücker M. Indications and contraindications for modern compression therapy. Wien Med Wochenschr. 2018;168:228–235. doi: 10.1007/s10354-017-0605-z. PubMed DOI

Rabe E, Partsch H, Morrison N, Meissner MH, Mosti G, Lattimer CR, Carpentier PH, et al. Risks and contraindications of medical compression treatment - a critical reappraisal. An international consensus statement. Phlebology. 2020;35:447–460. doi: 10.1177/0268355520909066. PubMed DOI PMC

Gohel M, Davies A. Pharmacological agents in the treatment of venous disease: an update of the available evidence. Curr Vasc Pharmacol. 2009;7:303–308. doi: 10.2174/157016109788340758. PubMed DOI

Castro-Ferreira R, Cardoso R, Leite-Moreira A, Mansilha A. The role of endothelial dysfunction and inflammation in chronic venous disease. Ann Vasc Surg. 2018;46:380–393. doi: 10.1016/j.avsg.2017.06.131. PubMed DOI

Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F, Pekarek L, et al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J Clin Med. 2021;10:3239. doi: 10.3390/jcm10153239. PubMed DOI PMC

Bouzeghrane F, Zhang X, Gevry G, Raymond J. Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice. J Vasc Surg. 2008;48:1575–1584. doi: 10.1016/j.jvs.2008.07.050. PubMed DOI

Fejfarová V, Jirkovská A, Dubský M, Game F, Vydláková J, Sekerková A, Franeková J, et al. An alteration of lymphocytes subpopulations and immunoglobulins levels in patients with diabetic foot ulcers infected particularly by resistant pathogens. J Diabetes Res. 2016;2016:2356870. doi: 10.1155/2016/2356870. PubMed DOI PMC

Fejfarová V, Hanzlíková D, Franců M, Jirkovská A, Bém R, Dubský M, Skibová J. Leg ulcers - is there any argument for podiatric wound care? DFSG Abstract Book 2010;9:84. 9th Scientific Meeting of the Diabetic Foot Study Group; Uppsala, Sweden. 17–19 September 2010.

Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, Bush RL, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8:342–352. doi: 10.1016/j.jvsv.2019.12.075. doi: 10.1016/j.jvsv.2019.12.075. Erratum in: J Vasc Surg Venous Lymphat Disord 2021;9:2. PubMed DOI

Chronic venous insufficiency and venous leg ulcers: Aetiology, on the pathophysiology-based treatment